Top 10 Cannabis Raises and Investors in the U.S. – January 1st – March 31st, 2026
Several interesting transactions closed in the Cannabis sector over the past quarter. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
Merger/Acquisition
- MTL Cannabis, a flower-first company for the modern street, was acquired by Canopy Growth for $131.27 million.
Buyout/LBO
- Green Leaf Virginia, cultivates, produces, manufactures, distributes, and sells cannabis services based in Richmond, Virginia, was acquired by Millstreet Capital Management through a $130 million LBO.
PIPE
- Artelo Biosciences, biopharmaceutical company that develops therapeutics that target lipid signaling pathways, received $11 million of development capital.
- Cannara Biotech, premium-grade cannabis and cannabis-derivative products for Canadian markets, received $4.62 million of development capital from Phoenician Capital.
- Enveric Biosciences, novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders, received $5 million of development capital.
Later Stage VC
- Curio Wellness, cannabis wellness platform that supports physical and mental well-being through science-informed products, raised $5.27 million of venture funding.
- Praetorian Global, cannabis-based products that deliver indigenous community benefits from harvesting raw ingredients, raised $49.65 million of venture funding.
Early Stage VC
- Willie’s Remedy+, beverage brand that provides a modern alternative to alcohol, raised $15 million of Series A venture funding in a deal led by Left Lane Capital.
Seed Round
- KSHN Pouch Co., smokeless cannabis pouches that provide a natural alternative to smoking and more, raised $1.38 million of seed funding.
- Magic Cactus, beverage brand that offers non-alcoholic drinks, raised $1.30 million through a combination of Debt and Seed funding.
#castleplacement #capitalraising #privateequity #venturecapital #investment #cannabis
Raheem Suleman
Managing Director
Over two decades of experience in capital markets across capital raising, FX, futures, and stocks. Expertise in both business and technical aspects of trading and relationship management. Valuable insights into Asian and Middle Eastern capital markets. Broad understanding of the financial markets, and the insurance and reinsurance sectors. Extensive experience in the hospitality industry, managing multiple properties with responsibilities ranging from capital raising to daily operations. Completed the executive education program in private equity at the Wharton School. B.S. in Economics and Finance from the University of Waterloo. FINRA Series 7 and 63 licensed.
- Email: rsuleman@castleplacement.com
- (C) (646) 852-8007
Raheem Suleman
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: rsuleman@castleplacement.com
(C) (646) 852-8007
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
